Seven Mile Advisory’s Merck MRK Stock Holding History

Seven Mile Advisory’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$591K	Sell	4,571 -562	-11%	-$65.8K	0.4%	46
2026 Q1	$617K	Sell	5,133 -2,379	-32%	-$275K	0.45%	39
2025 Q4	$791K	Buy	7,512 +817	+12%	+$76.7K	0.14%	82
2025 Q3	$562K	Buy	6,695 +2,525	+61%	+$208K	0.09%	119
2025 Q2	$330K	Sell	4,170 -1,155	-22%	-$91.8K	0.2%	107
2025 Q1	$478K	Sell	5,325 -534	-9%	-$49.9K	0.32%	59
2024 Q4	$583K	Buy	5,859 +951	+19%	+$98K	0.37%	49
2024 Q3	$557K	Buy	4,908 +165	+3%	+$19.6K	0.37%	53
2024 Q2	$587K	Buy	4,743 +105	+2%	+$13.5K	0.43%	45
2024 Q1	$612K	Buy	4,638 +43	+0.9%	+$5.3K	0.46%	43
2023 Q4	$501K	Buy	4,595 +179	+4%	+$18.6K	0.43%	52
2023 Q3	$455K	Sell	4,416 -171	-4%	-$18.4K	0.48%	49
2023 Q2	$529K	Buy	+4,587	New	+$521K	0.62%	39

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Seven Mile Advisory's MRK Position: Q2 2026 in Review

Seven Mile Advisory reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $65.8K and leaving 4,571 shares worth $591K. The position accounts for 0.4% of the portfolio, ranked #46.

Seven Mile Advisory first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $791K in Q4 2025. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Seven Mile Advisory held 4,571 shares of Merck worth $591K as of Q2 2026.
Seven Mile Advisory sold 562 Merck shares in Q2 2026, an estimated $65.8K.
Merck made up 0.4% of Seven Mile Advisory's portfolio in Q2 2026, its #46 holding.
Seven Mile Advisory first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
Seven Mile Advisory's Merck position peaked at $791K in Q4 2025.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.